Black Bird Biotech, Inc.’s (OTCPINK: BBBT) interview, Mr. Fabian Deneault, President.


See the full episode at:

This week New to the Street TV welcomes back Black Bird Biotech, Inc.’s (OTCPINK: BBBT), Mr. Fabian G. Deneault, President, who talks with TV Anchor Jane King about the Company’s product, MiteXstream, an EPA-registered plant-based non-poisonous biopesticide. Fabian gives the viewers a corporate overview of last year’s operations on the MiteXstream product, raising money, paying down debts, ending the year with good cash-on-hand, and marketing efforts. In 2022, the focus is to grow the Company’s sales and marketing and the pending EPA approvals for retail distributions for consumers who can use the MiteXstream products for home and garden needs. Also, he explained the bed bug product currently being tested for EPA certification. Because the MiteXstream product is a non-poisonous plant base and food-grade biotech solution, Fabian feels that the product is a perfect fit for organic farms. The Company continues to seek an up listing on its BBBT stock to a higher tier stock exchange and will reapply for the OTCQB listing later in 2022.

To make sure you never miss a video from New to the Street, click here to subscribe:

Follow New to the Street on Twitter:

Follow New to the Street on Facebook:

Follow New to the Street on Instagram:

Follow New to the Street on Rumble:

About New to the Street:

Subscribe to our Mailing List: